Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2021

Mar 3, 2021

29745_dirs_2021-03-03_f0c9e425-b35a-4b91-9e16-400a9d0f0c2b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-03-01

Reporting Person: Hakim Anat (SVP, GC & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-01 Common Stock M 7928 Acquired 7928 Direct
2021-03-01 Common Stock F 3493 $204.89 Disposed 4435 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-01 Restricted Stock Unit $ M 7928 Disposed Common Stock (7928.0) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The Restricted Stock Units vest in two installments, 7,928 on March 1, 2021 and 7,929 on March 1, 2022.